Shrinivas Joshi

Dr. Shrinivas Joshi


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2013 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
SJShrinivas Joshi
Shrinivas Joshi
UMUttam A. More
Uttam A. More
DDDr. Sheshagiri Ravindra Dixit
Dr. Sheshagiri Ravindra Dixit
HKHaresh H. Korat
Haresh H. Korat
Tejraj M. AminabhaviTejraj M. Aminabhavi
Tejraj M. Aminabhavi
ABAravind M. Badiger
Aravind M. Badiger

13 October 2021 in Applied Organometallic Chemistry
Verified
Journal Article
Open access
PDF file
ANAravind R Nesaragi
Aravind R Nesaragi
RKRavindra R. Kamble
Ravindra R. Kamble
SHSwati R. Hoolageri
Swati R. Hoolageri
AMAhmedraza Mavazzan
Ahmedraza Mavazzan
SMSuresh F. Madar
Suresh F. Madar
SJShrinivas Joshi
Shrinivas Joshi
Since 2019, the infection of SARS‐CoV‐2 has been spreading worldwide and caused potentially lethal health problems. In view of this, the present study explores the most commodious and environmentally benign synthetic protocol for the synthesis of tetrahydrobenzo[b]pyran and pyrano[2,3‐d]pyrimidinones as SARS‐CoV‐2 inhibitors via three‐component cycloaddition of aromatic aldehyde, malononitrile, and dimedone/barbituric acid in water. Lemon peel from juice factory waste, namely, lemon (Citrus limon), sweet lemon (C. limetta), and Kaffir lime or Citron (C. hystrix), effectually utilized to obtain WELPSA, WESLPSA, and WEKLPSA, respectively, for the synthesis of title compounds. The catalyst was characterized by scanning electron microscope (SEM) and energy‐dispersive x‐ray spectroscopy (EDX). The concentration of sodium, potassium, calcium, and magnesium in the catalyst (WELPSA) was determined using atomic absorption spectrometry (AAS). The current approach manifests numerous notable advantages that include ease of preparation, handling and benignity of the catalyst, low cost, green reaction conditions, facile workup, excellent yields (93%–97%) with extreme purity, and recyclability of the catalyst. Compounds were docked on the crystal structure of SARS‐CoV‐2 (PDB: 6M3M). The consensus score obtained in the range 2.47–4.63 suggests that docking study was optimistic indicating the summary of all forces of interaction between ligands and the protein.

1 January 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SJShrinivas Joshi
Shrinivas Joshi
DDDr. Sheshagiri Ravindra Dixit
Dr. Sheshagiri Ravindra Dixit
VKVenkatarao H. Kulkarni
Venkatarao H. Kulkarni
Christian LherbetChristian Lherbet
Christian Lherbet
MNMallikarjuna Nadagouda
Mallikarjuna Nadagouda
Tejraj M. AminabhaviTejraj M. Aminabhavi
Tejraj M. Aminabhavi

31 August 2014 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SJShrinivas Joshi
Shrinivas Joshi
DDDr. Sheshagiri Ravindra Dixit
Dr. Sheshagiri Ravindra Dixit
UMUttam A. More
Uttam A. More
Tejraj M. AminabhaviTejraj M. Aminabhavi
Tejraj M. Aminabhavi
VKVenkatrao H. Kulkarni
Venkatrao H. Kulkarni
AGAndanappa K. Gadad
Andanappa K. Gadad
The emergence of drug resistant strains of important human pathogens has created an urgent necessity to find new targets and novel antitubercular agents. According to the literature survey, we noticed that enoyl ACP reductase is one of the most promising targets. This enzyme is the most important catalyst for the FAS II synthesis of mycolic acid, which is the most essential component of the mycobacterial cell wall. This review summarizes the progress made in the design of enoyl ACP reductase inhibitors and the role played by 3D-structure of the enzyme in drug design process.

27 August 2015 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
SJShrinivas Joshi
Shrinivas Joshi
UMUttam A. More
Uttam A. More
DPDeepak Parkale
Deepak Parkale
Tejraj M. AminabhaviTejraj M. Aminabhavi
Tejraj M. Aminabhavi
AGAndanappa K. Gadad
Andanappa K. Gadad
RJRahul Jawarkar
Rahul Jawarkar

19 May 2012 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
SJShrinivas Joshi
Shrinivas Joshi
KMK. Manish
K. Manish
ABAravind Badiger
Aravind Badiger